Factors Affecting the Outcomes of COVID-19 Patients Treated at Dr. M. Djamil Padang General Hospital

Yessy Susanty Sabri, Dewi Wahyu Fitrina, M. Hari Nandi Pinto, Lusi Agustini Arda, Nova Indriyani, Kornelis Aribowo, Ilham Ilham, Dimas Bayu Firdaus

Abstract


Background: COVID-19 has spread rapidly throughout the world with high morbidity and mortality. This study aimed to determine the factors that influenced the outcomes of COVID-19 patients treated at RSUP. Dr. M. Djamil Padang.

Methods: This was an observational analytic study conducted with a retrospective cohort design on COVID-19 patients at RSUP Dr. M. Djamil Padang. Data were taken from medical records from January to March 2021. Association between comorbidities and the outcome of COVID-19 patients were analyzed using Chi- Square/Fisher Exact Test.

Results: Majority of the patients were female (56.4%) and aged above 50 years (64.3%). Hypertension was the most common comorbidity (41.1%). Diabetes mellitus affected the final outcome of treatment. The number of comorbidities the patients had was associated with a worse outcome for COVID-19.

Conclusion: Most of COVID-19 patients at RSUP Dr. M. Djamil Padang were male and more than 50 years old. There was a correlation between age, gender, and comorbidities in COVID-19 patients with the outcomes.


Keywords


Comorbidities, COVID-19, Outcome COVID-19

Full Text:

PDF

References


Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents. 2020;55(5):105955.

Wang R, Pan M, Zhang X, Han M, Fan X, Zhao F, et al. Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China. Int J Infect Dis. 2020 Jun;95:421–8.

Satuan Tugas Penanganan COVID-19. Analisis data COVID-19 indonesia (update per 28 februari 2021) [Internet]. Satuan Tugas Penanganan COVID-19. 2021 [cited 2021 Mar 13]. Available from: https://covid19.go.id/p/berita/analisis-data-covid-19-indonesia-update-28-februari-2021

Tim IT DISKOMINFO Sumbar. Data pantauan COVID-19 provinsi sumatera barat [Internet]. Pemerintah Provinsi Sumatera Barat. 2021 [cited 2021 Mar 13]. Available from: https://corona.sumbarprov.go.id/

Pemerintah Kota Padang Dinas Komunikasi dan Informatika. Covid-19 Kota Padang [Internet]. Dinas Komunikasi dan Informatika Kota Padang. 2021 [cited 2021 Jun 30]. Available from: http://corona.padang.go.id/

Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One. 2020;15(11):e0241955.

Verma AA, Hora T, Jung HY, Fralick M, Malecki SL, Lapointe-Shaw L, et al. Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area. Can Med Assoc J. 2021;193(12):E410 LP-E418.

Siordia JAJ. Epidemiology and clinical features of COVID-19: A review of current literature. J Clin Virol. 2020;127:104357.

Khedr EM, Daef E, Mohamed-Hussein A, Mostafa EF, Zein M, Hassany SM, et al. Impact of comorbidities on COVID-19 outcome. medRxiv : the preprint server for health sciences. 2020.

Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg Heal - West Pacific. 2021;9:100108.

Wen S, Prasad A, Freeland K, Podury S, Patel J, Subedi R, et al. Clinical Characteristics and Outcomes of COVID-19 in West Virginia. Viruses. 2021;13(5).

Das SK. The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19). Indian J Clin Biochem. 2020;35(4):385–96.

Giannouchos T V, Sussman RA, Mier JM, Poulas K, Farsalinos K. Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases. Eur Respir J. 2020 Jan;2002144.

Zaenab A, Jose V, Cynthia C-J, Yousuf Z, Claudia M, Hamed S. The Effects of Co-morbidities on COVID-19 Patients Admitted to the Hospital. Fam Med Med Sci Res. 2021;10(2):1–7.

Phelps M, Christensen DM, Gerds T, Fosbøl E, Torp-Pedersen C, Schou M, et al. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. Eur Hear journal Qual care Clin outcomes. 2021;7(2):172–80.

Osibogun A, Balogun M, Abayomi A, Idris J, Kuyinu Y, Odukoya O, et al. Outcomes of COVID-19 patients with comorbidities in southwest Nigeria. PLoS One. 2021;16(3):e0248281.

Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology. 2021;64(1):36–47.

Alwafi H, Naser AY, Qanash S, Brinji AS, Ghazawi MA, Alotaibi B, et al. Predictors of length of hospital stay, mortality, and outcomes among hospitalised COVID-19 patients in saudi arabia: a cross-sectional study. J Multidiscip Healthc. 2021;14:839–52.

Ugwueze C V, Ezeokpo BC, Nnolim BI, Agim EA, Anikpo NC, Onyekachi KE. COVID-19 and Diabetes Mellitus: The Link and Clinical Implications. Dubai Diabetes Endocrinol J. 2020;26(2):69–77.

Fresán U, Guevara M, Trobajo-Sanmartín C, Burgui C, Ezpeleta C, Castilla J. Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study. J Clin Med. 2021;10(6).

Bae S, Kim SR, Kim M-N, Shim WJ, Park S-M. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. 2021;107(5):373–80.

Abhilasha, Mitra P, Suri S, Goyal T, Misra R, Singh K, et al. Association of Comorbidities with Coronavirus Disease 2019: A Review. Ann Natl Acad Med Sci. 2020;56(2):102–11.

Zhou Y, Yang Q, Chi J, Dong B, Lv W, Shen L, et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. Int J Infect Dis. 2020;99:47–56.

Siepmann T, Sedghi A, Barlinn J, de With K, Mirow L, Wolz M, et al. Association of history of cerebrovascular disease with severity of COVID-19. J Neurol. 2021;268(3):773–84.

Gao Y-D, Ding M, Dong X, Zhang J-J, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76(2):428–55.

Rossouw TM, Boswell MT, Nienaber AG, Moodley K. Comorbidity in context: Part 1. Medical considerations around HIV and tuberculosis during the COVID-19 pandemic in South Africa. South African Med J. 2020;110(7):621–4.




DOI: https://doi.org/10.36497/jri.v40i3.273

Refbacks

  • There are currently no refbacks.




Copyright (c) 2022 Jurnal Respirologi Indonesia

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


INDEXING & PARTNER

SINTA Garuda Indonesian Scientific Journal Database (ISJD) Indonesia One Search (IOS) Crossref

ROAD-ISSN Dimensions Google Scholar 

 

Jurnal Respirologi Indonesia
pISSN: 0853-7704 - eISSN: 2620-3162
Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia
Phone: +62-21-2247-4845
Email: editor@jurnalrespirologi.org


An official publication by
the Indonesian Society of Respirology (ISR)

Creative Commons License
Creative Commons Attribution-NonCommercial 4.0 International License

Statcounter